Literature DB >> 3595701

Longitudinal effects of pregnancy on the pharmacokinetics of theophylline.

M J Gardner, M Schatz, L Cousins, R Zeiger, E Middleton, W J Jusko.   

Abstract

The effects of pregnancy on the disposition of theophylline were assessed in 10 patients throughout pregnancy and post-partum. The clearance relative to total theophylline concentrations was only slightly affected during the first two trimesters (2.61 +/- 0.63 l/h and 2.85 +/- 1.05 l/h), while a statistically significant reduction was evident late in pregnancy (2.05 +/- 0.49 l/h). Post-partum clearance values (2.16 +/- 2.81 l/h) suggest an ongoing suppression relative to pre-pregnancy levels. A similar pattern was evident with clearance values based on free theophylline plasma concentrations (p = 0.12). Absolute volume of distribution increased in concert with gestation, suggesting that theophylline partitions into the enlarged tissue spaces. In addition, theophylline binding to plasma proteins decreased, albeit insignificantly, during the second (fraction bound = 29%) and third (32%) trimesters compared to post-partum values (41%). Increases in half-life during the third trimester (13.00 +/- 2.31 h vs 9.53 +/- 3.53 h post-partum) were highly significant. This change reflects the net effect of reduced clearance and increased distribution. Breast feeding had no effect on the disposition of theophylline, although the transfer of this compound into breast milk was confirmed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3595701     DOI: 10.1007/bf00607577

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  32 in total

1.  High-pressure liquid chromatographic and spectrophotometric assays for theophylline in biological fluids.

Authors:  W J Jusko; A Poliszczuk
Journal:  Am J Hosp Pharm       Date:  1976-11

2.  Phenytoin and phenobarbitone plasma clearance during pregnancy.

Authors:  K I Mygind; M Dam; J Christiansen
Journal:  Acta Neurol Scand       Date:  1976-08       Impact factor: 3.209

3.  Metabolism and distribution of labeled theophylline in the pregnant rat. Impairment of theophylline metabolism by pregnancy and absence of a blood-brain barrier in the fetus.

Authors:  M J Arnaud; I Bracco; C Welsch
Journal:  Pediatr Res       Date:  1982-03       Impact factor: 3.756

4.  Antiepileptic drugs: metabolism in pregnancy.

Authors:  M Dam; J Christiansen; O Munck; K I Mygind
Journal:  Clin Pharmacokinet       Date:  1979 Jan-Feb       Impact factor: 6.447

5.  Absolute bioavailability of oral theophylline.

Authors:  L Hendeles; M Weinberger; L Bighley
Journal:  Am J Hosp Pharm       Date:  1977-05

Review 6.  Use of benzodiazepines during pregnancy, labour and lactation, with particular reference to pharmacokinetic considerations.

Authors:  J H Kanto
Journal:  Drugs       Date:  1982-05       Impact factor: 9.546

7.  Phenobarbital pharmacokinetics and salivary and serum concentrations in pregnancy.

Authors:  P V Luoma; J E Heikkinen; P R Ylöstalo
Journal:  Ther Drug Monit       Date:  1982       Impact factor: 3.681

8.  Factors influencing theophylline serum protein binding.

Authors:  L M Shaw; L Fields; R Mayock
Journal:  Clin Pharmacol Ther       Date:  1982-10       Impact factor: 6.875

9.  Kinetics of theophylline transfer to breast milk.

Authors:  G P Stec; P Greenberger; T I Ruo; T Henthorn; Y Morita; A J Atkinson; R Patterson
Journal:  Clin Pharmacol Ther       Date:  1980-09       Impact factor: 6.875

10.  Drug binding to plasma proteins during human pregnancy and in the perinatal period. Studies on cloxacillin and alprenolol.

Authors:  L Herngren; M Ehrnebo; L O Boréus
Journal:  Dev Pharmacol Ther       Date:  1983
View more
  9 in total

1.  Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling.

Authors:  Khaled Abduljalil; Penny Furness; Trevor N Johnson; Amin Rostami-Hodjegan; Hora Soltani
Journal:  Clin Pharmacokinet       Date:  2012-06-01       Impact factor: 6.447

Review 2.  Plasma protein binding of drugs in pregnancy and in neonates.

Authors:  L J Notarianni
Journal:  Clin Pharmacokinet       Date:  1990-01       Impact factor: 6.447

Review 3.  Asthma treatment during pregnancy. What can be safely taken?

Authors:  M Schatz
Journal:  Drug Saf       Date:  1997-05       Impact factor: 5.606

Review 4.  Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.

Authors:  Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

5.  Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women.

Authors:  André Dallmann; Ibrahim Ince; Juri Solodenko; Michaela Meyer; Stefan Willmann; Thomas Eissing; Georg Hempel
Journal:  Clin Pharmacokinet       Date:  2017-12       Impact factor: 6.447

6.  Application of a Physiologically Based Pharmacokinetic Approach to Predict Theophylline Pharmacokinetics Using Virtual Non-Pregnant, Pregnant, Fetal, Breast-Feeding, and Neonatal Populations.

Authors:  Khaled Abduljalil; Iain Gardner; Masoud Jamei
Journal:  Front Pediatr       Date:  2022-05-12       Impact factor: 3.569

7.  A physiologically based pharmacokinetic model to predict disposition of CYP2D6 and CYP1A2 metabolized drugs in pregnant women.

Authors:  Alice Ban Ke; Srikanth C Nallani; Ping Zhao; Amin Rostami-Hodjegan; Nina Isoherranen; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2013-01-25       Impact factor: 3.922

8.  Piperaquine Exposure Is Altered by Pregnancy, HIV, and Nutritional Status in Ugandan Women.

Authors:  Emma Hughes; Marjorie Imperial; Erika Wallender; Richard Kajubi; Liusheng Huang; Prasanna Jagannathan; Nan Zhang; Abel Kakuru; Paul Natureeba; Moses W Mwima; Mary Muhindo; Norah Mwebaza; Tamara D Clark; Bishop Opira; Miriam Nakalembe; Diane Havlir; Moses Kamya; Philip J Rosenthal; Grant Dorsey; Francesca Aweeka; Radojka M Savic
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

Review 9.  Clinical pharmacokinetics of vasodilators. Part II.

Authors:  R Kirsten; K Nelson; D Kirsten; B Heintz
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.